Other languages Maxigen Biotech Inc.

Equities

1783

TW0001783009

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 20/05/2024 BST			5-day change	1st Jan Change
43.4 ^TWD	-0.91%		-0.34%	-10.33%

05-06	Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-21	Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-06
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-21
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08
Maxigen Biotech Inc. Declares Dividend, Payable on October 12, 2023	23/08/23
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	26/07/23
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2022 to December 31, 2022	03/05/23
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
Maxigen Biotech Inc. Announces Executive Changes	22/03/23
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/10/22
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/08/22
Maxigen Biotech Inc. Announces Resignation of Lu Min Hsuan as Chief Internal Auditor	13/05/22
Maxigen Biotech Inc. Approves the Appointment of You Wan-How, Manager as Financial Officer and Accounting Officer	03/05/22
Maxigen Biotech Inc. Appoints Lin Yung-Hsiang to Nomination Committee	03/05/22
Maxigen Biotech Inc. Appoints Members of the Company's Risk Management Committee	03/05/22
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	03/05/22
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	23/03/22
Maxigen Biotech Inc. Announces Resignation of Yu, Yi Hua as Financial Officer and Accounting Officer	21/03/22
Maxigen Biotech Inc. Appoints Lu Min Hsuan as Chief Internal Auditor	30/12/21
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	09/11/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Maxigen Biotech Inc.

Equities

1783

TW0001783009

Other languages

Filters